Eric Rouseau

NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production.

C. Lugnier, G. Boire, Issaka Yougbare, 2013, Canadian journal of physiology and pharmacology.